RAXONE Trademark

Trademark Overview


On Thursday, May 12, 2022, a trademark application was filed for RAXONE with the United States Patent and Trademark Office. The USPTO has given the RAXONE trademark a serial number of 97407005. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Santhera Pharmaceuticals (Schweiz) AG. The RAXONE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss

chemicals used in industry and science

computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss
raxone

General Information


Serial Number97407005
Word MarkRAXONE
Filing DateThursday, May 12, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7172934
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements


Goods and Servicespharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss
Goods and Serviceschemicals used in industry and science
Goods and Servicescomputer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHIESI FARMACEUTICI S.P.A.
Party Type31 - New Owner After Registration
Legal Entity Type35 - NOT AVAILABLE
AddressPARMA 43122
IT

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPratteln CH-4133
CH

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPratteln CH-4133
CH

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPratteln CH-4133
CH

Trademark Events


Event DateEvent Description
Wednesday, October 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 2, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023ASSIGNED TO EXAMINER
Thursday, June 30, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, June 30, 2022ASSIGNED TO LIE
Tuesday, May 17, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 16, 2022NEW APPLICATION ENTERED